These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Hansson O; Zetterberg H; Vanmechelen E; Vanderstichele H; Andreasson U; Londos E; Wallin A; Minthon L; Blennow K Neurobiol Aging; 2010 Mar; 31(3):357-67. PubMed ID: 18486992 [TBL] [Abstract][Full Text] [Related]
4. No correlation between time-linked plasma and CSF Abeta levels. Le Bastard N; Aerts L; Leurs J; Blomme W; De Deyn PP; Engelborghs S Neurochem Int; 2009 Dec; 55(8):820-5. PubMed ID: 19695299 [TBL] [Abstract][Full Text] [Related]
5. Plasma beta carotene in Alzheimer's disease. Association with cerebrospinal fluid beta-amyloid 1-40, (Abeta40), beta-amyloid 1-42 (Abeta42) and total Tau. Stuerenburg HJ; Ganzer S; Müller-Thomsen T Neuro Endocrinol Lett; 2005 Dec; 26(6):696-8. PubMed ID: 16380679 [TBL] [Abstract][Full Text] [Related]
6. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease. Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377 [TBL] [Abstract][Full Text] [Related]
7. Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment. Hansson O; Zetterberg H; Buchhave P; Andreasson U; Londos E; Minthon L; Blennow K Dement Geriatr Cogn Disord; 2007; 23(5):316-20. PubMed ID: 17374949 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic utility of APOE, soluble CD40, CD40L, and Abeta1-40 levels in plasma in Alzheimer's disease. Ait-ghezala G; Abdullah L; Volmar CH; Paris D; Luis CA; Quadros A; Mouzon B; Mullan MA; Keegan AP; Parrish J; Crawford FC; Mathura VS; Mullan MJ Cytokine; 2008 Nov; 44(2):283-7. PubMed ID: 18835787 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of plasma Abeta40 and Abeta42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment. Kester MI; Verwey NA; van Elk EJ; Scheltens P; Blankenstein MA Neurobiol Aging; 2010 Apr; 31(4):539-40; author reply 541. PubMed ID: 18963255 [No Abstract] [Full Text] [Related]
10. Amyloid beta peptides in cerebrospinal fluid as profiled with surface enhanced laser desorption/ionization time-of-flight mass spectrometry: evidence of novel biomarkers in Alzheimer's disease. Lewczuk P; Esselmann H; Groemer TW; Bibl M; Maler JM; Steinacker P; Otto M; Kornhuber J; Wiltfang J Biol Psychiatry; 2004 Mar; 55(5):524-30. PubMed ID: 15023581 [TBL] [Abstract][Full Text] [Related]
11. High levels of circulating Abeta42 are sequestered by plasma proteins in Alzheimer's disease. Kuo YM; Emmerling MR; Lampert HC; Hempelman SR; Kokjohn TA; Woods AS; Cotter RJ; Roher AE Biochem Biophys Res Commun; 1999 Apr; 257(3):787-91. PubMed ID: 10208861 [TBL] [Abstract][Full Text] [Related]
12. Serum amyloid p component as a biomarker in mild cognitive impairment and Alzheimer's disease. Verwey NA; Schuitemaker A; van der Flier WM; Mulder SD; Mulder C; Hack CE; Scheltens P; Blankenstein MA; Veerhuis R Dement Geriatr Cogn Disord; 2008; 26(6):522-7. PubMed ID: 19052452 [TBL] [Abstract][Full Text] [Related]
13. Plasma amyloid-beta as a biomarker in Alzheimer's disease: the AIBL study of aging. Lui JK; Laws SM; Li QX; Villemagne VL; Ames D; Brown B; Bush AI; De Ruyck K; Dromey J; Ellis KA; Faux NG; Foster J; Fowler C; Gupta V; Hudson P; Laughton K; Masters CL; Pertile K; Rembach A; Rimajova M; Rodrigues M; Rowe CC; Rumble R; Szoeke C; Taddei K; Taddei T; Trounson B; Ward V; Martins RN; AIBL Research Group J Alzheimers Dis; 2010; 20(4):1233-42. PubMed ID: 20413897 [TBL] [Abstract][Full Text] [Related]
14. Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels. Fukumoto H; Tennis M; Locascio JJ; Hyman BT; Growdon JH; Irizarry MC Arch Neurol; 2003 Jul; 60(7):958-64. PubMed ID: 12873852 [TBL] [Abstract][Full Text] [Related]